Fermenta Biotech Ltd
FERMENTAFermenta Biotech Ltd
FERMENTA
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 142.23 | 4.22 | 0.31% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.53 | 6.56 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
DIL is in the business of primarily bulk drugs and enzymes, renting property, entertainment and utilization of surplus funds for its treasury operations. The Company's segments include Property, Treasury, Entertainment and Chemicals.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 156.06 | 166.81 | 311.01 | 415.82 | 304.03 | 385.54 | 406.66 | 358.54 | 347.47 | 383.07 | ||||||||||
Raw Materials | 64.45 | 82.10 | 85.19 | 105.08 | 106.11 | 163.12 | 146.88 | 131.04 | 104.02 | 319.40 | ||||||||||
| Power & Fuel Cost | 8.67 | 9.75 | 10.86 | 13.88 | 12.74 | 14.23 | 20.35 | 18.24 | 19.78 | |||||||||||
| Employee Cost | 27.97 | 30.84 | 39.83 | 53.18 | 50.03 | 58.22 | 62.97 | 58.00 | 58.55 | |||||||||||
| Selling & Administrative Expenses | 18.17 | 18.66 | 42.70 | 53.10 | 47.57 | 41.03 | 46.13 | 47.53 | 40.65 | |||||||||||
| Operating & Other expenses | 15.35 | 10.71 | 30.46 | 28.76 | 9.07 | 17.99 | 59.83 | 105.41 | 92.19 | |||||||||||
EBITDA | 21.45 | 14.75 | 101.97 | 161.82 | 78.51 | 90.95 | 70.50 | -1.68 | 32.28 | 63.67 | ||||||||||
| Depreciation/Amortization | 8.35 | 10.31 | 12.36 | 11.89 | 15.00 | 20.31 | 25.56 | 28.25 | 24.72 | 25.11 | ||||||||||
| PBIT | 13.10 | 4.44 | 89.61 | 149.93 | 63.51 | 70.64 | 44.94 | -29.93 | 7.56 | 38.56 | ||||||||||
| Interest & Other Items | 6.15 | 9.96 | 13.63 | 21.23 | 20.09 | 19.00 | 17.98 | 21.37 | 17.43 | 15.70 | ||||||||||
| PBT | 6.95 | -5.52 | 75.98 | 128.70 | 43.42 | 51.64 | 26.96 | -51.30 | -9.87 | 22.86 | ||||||||||
| Taxes & Other Items | 8.10 | 5.89 | 42.25 | 11.26 | -16.11 | 6.12 | 11.50 | -0.23 | 13.19 | 14.40 | ||||||||||
| Net Income | -1.15 | -11.41 | 33.73 | 117.44 | 59.53 | 45.52 | 15.46 | -51.07 | -23.06 | 8.46 | ||||||||||
| EPS | -0.42 | -4.15 | 12.26 | 42.68 | 21.12 | 15.78 | 5.31 | -17.35 | -7.84 | 2.87 | ||||||||||
| DPS | 0.21 | 0.21 | 0.21 | 0.42 | 5.00 | 2.50 | 1.25 | 1.25 | 1.25 | 1.25 | ||||||||||
| Payout ratio | — | — | 0.02 | 0.01 | 0.24 | 0.16 | 0.24 | — | — | 0.43 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Fermenta Biotech Ltd | -52.18 | 4.22 | 0.31% |
| Sun Pharmaceutical Industries Ltd | 45.35 | 6.47 | 0.75% |
| Cipla Ltd | 28.51 | 4.38 | 0.89% |
| Torrent Pharmaceuticals Ltd | 68.45 | 16.54 | 0.84% |
Price Comparison
Compare FERMENTA with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
Dividend Yield
Current dividend yield is 0.31%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹3.06 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateAug 6, 2024
Dividend/Share
₹1.25
Ex DateEx Date
Aug 6, 2024
Cash Dividend
Ex DateEx DateSep 22, 2023
Dividend/Share
₹1.25
Ex DateEx Date
Sep 22, 2023
Cash Dividend
Ex DateEx DateAug 4, 2022
Dividend/Share
₹1.25
Ex DateEx Date
Aug 4, 2022
Cash Dividend
Ex DateEx DateAug 25, 2021
Dividend/Share
₹2.50
Ex DateEx Date
Aug 25, 2021
Cash Dividend
Ex DateEx DateNov 22, 2019
Dividend/Share
₹5.00
Ex DateEx Date
Nov 22, 2019
Net profit of Fermenta Biotech reported to Rs 11.38 crore in the quarter ended September 2024 as against net loss of Rs 28.56 crore during the previous quarter ended September 2023. Sales rose 66.98% to Rs 95.03 crore in the quarter ended September 2024 as against Rs 56.91 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales95.0356.91 67 OPM %19.76-24.46 - PBDT17.97-15.70 LP PBT11.82-21.64 LP NP11.38-28.56 LP Powered by Capital Market - Live
Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Net loss of Fermenta Biotech reported to Rs 5.82 crore in the quarter ended June 2024 as against net profit of Rs 1.83 crore during the previous quarter ended June 2023. Sales declined 5.24% to Rs 78.13 crore in the quarter ended June 2024 as against Rs 82.45 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales78.1382.45 -5 OPM %1.0213.26 - PBDT0.198.16 -98 PBT-5.932.21 PL NP-5.821.83 PL Powered by Capital Market - Live
Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live
Fermenta Biotech Suspends Operations At Kullu Plant
Fermenta Biotech standalone net profit declines 6.20% in the March 2022 quarter
Weekly Tactical Pick | Fermenta Biotech
Fermenta Biotech plans partial shutdown to expand capacity at Dahej facility
Stocks that will see action on October 6
Fermenta Biotech undertakes partial shutdown of its Dahej unit
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -3.53%, vs industry avg of 9.03%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.19% to 0.09%